ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,139Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 1278

$753K Total Retail Price of All Prescriptions

Rank: 36 out of 1278

672 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,544 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 437 385 1 2
SIMVASTATIN 402 334 2 3
METFORMIN HCL 261 220 3 4
LISINOPRIL 244 218 4 1
ZOLPIDEM TARTRATE 223 196 5 16
PRAVASTATIN SODIUM 218 191 6 14
SYNTHROID 210 198 7 63
HYDROCODONE-ACETAMINOPHEN 187 149 S3 8 7
METOPROLOL TARTRATE 170 166 9 9
HYDROCHLOROTHIAZIDE 153 149 10 8
AMLODIPINE BESYLATE 149 146 11 5
OMEPRAZOLE 147 124 12 6
TRAMADOL HCL 133 112 13 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 104 14 30
FUROSEMIDE 125 114 15 10
CITALOPRAM HBR 125 112 15 22
ATENOLOL 124 89 17 11
TAMSULOSIN HCL 122 106 18 32
GLIMEPIRIDE 117 110 19 61
ALLOPURINOL 103 102 20 36
CRESTOR 101 91 21 31
PANTOPRAZOLE SODIUM 99 76 22 34
FLUTICASONE PROPIONATE 99 92 22 24
POTASSIUM CHLORIDE 98 83 24 21
RANITIDINE HCL 96 82 25 20
VERAPAMIL ER 90 76 26 84
ESTRADIOL 88 88 R 27 71
WARFARIN SODIUM 86 73 28 17
LEVOXYL 86 85 28 94
ALENDRONATE SODIUM 86 86 28 18
LOVASTATIN 85 79 31 13
LOSARTAN POTASSIUM 83 79 32 19
METOPROLOL SUCCINATE 81 81 33 23
IPRATROPIUM BROMIDE 79 76 34 212
ATORVASTATIN CALCIUM 75 64 35 15
EVISTA 74 63 36 99
PEN NEEDLE 72 68 37 154
SPIRIVA 69 52 38 65
ACTOS 68 63 39 72
FLUOXETINE HCL 67 40 40 41
DOXAZOSIN MESYLATE 66 63 41 69
PROAIR HFA 65 28 42 26
LYRICA 64 29 43 104
CLOPIDOGREL 64 64 43 45
SERTRALINE HCL 61 60 45 28
NAPROXEN 59 48 46 70
PLAVIX 58 58 47 64
BYSTOLIC 57 57 48 136
OXYCODONE HCL 57 0 S2 48 27
CARVEDILOL 56 52 50 39
SINGULAIR 53 29 51 155
GABAPENTIN 50 49 52 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.